 Goldman Sachs Group Inc. lessened its position in shares of Kiniksa Pharmaceuticals Ltd NASDAQ:KNSA by 76.9 during the fourth quarter, according to the company in its most recent 13F filing with the Securities Exchange Commission. The fund owned 13,543 shares of the companys stock after selling 45,091 shares during the period. Goldman Sachs Group ... 